Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Seeger

Showing results (231-240 of 266) with videos related to

Pageof 27
Sort By:
Pediatric Blood & Cancer|April 20, 2022
Expression of neuroblastoma-related genes in bone marrow at end of high-risk neuroblastoma therapyShahab Asgharzadeh, Araz Marachelian, Judith G Villablanca, et al.
The New England Journal of Medicine|October 16, 1999
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer GroupK K Matthay, J G Villablanca, R C Seeger, et al.
Journal of Pediatric Hematology/Oncology|June 11, 1999
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survivalS G DuBois, Y Kalika, J N Lukens, et al.
Pediatric Blood & Cancer|June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COGChizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
GABAergic system gene expression predicts clinical outcome in patients with neuroblastomaStephen S Roberts, Motomi Mori, Patrick Pattee, et al.
Medical and Pediatric Oncology|July 24, 2001
Loss of heterozygosity for chromosome 14q in neuroblastomaP M Thompson, B A Seifried, S K Kyemba, et al.
Epidemiology (Cambridge, Mass.)|January 4, 2001
Residential pesticide exposure and neuroblastomaJ L Daniels, A F Olshan, K Teschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group studyJ M Maris, M J Weiss, C Guo, et al.
The New England Journal of Medicine|November 25, 2005
Chromosome 1p and 11q deletions and outcome in neuroblastomaEdward F Attiyeh, Wendy B London, Yael P Mossé, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 11, 2014
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology GroupRisa Teshiba, Shinya Kawano, Larry L Wang, et al.
Pageof 27

Showing results (231-240 of 266) with videos related to

Sort By:
Pageof 27
Pediatric Blood & Cancer|April 20, 2022
Expression of neuroblastoma-related genes in bone marrow at end of high-risk neuroblastoma therapyShahab Asgharzadeh, Araz Marachelian, Judith G Villablanca, et al.
The New England Journal of Medicine|October 16, 1999
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer GroupK K Matthay, J G Villablanca, R C Seeger, et al.
Journal of Pediatric Hematology/Oncology|June 11, 1999
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survivalS G DuBois, Y Kalika, J N Lukens, et al.
Pediatric Blood & Cancer|June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COGChizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
GABAergic system gene expression predicts clinical outcome in patients with neuroblastomaStephen S Roberts, Motomi Mori, Patrick Pattee, et al.
Medical and Pediatric Oncology|July 24, 2001
Loss of heterozygosity for chromosome 14q in neuroblastomaP M Thompson, B A Seifried, S K Kyemba, et al.
Epidemiology (Cambridge, Mass.)|January 4, 2001
Residential pesticide exposure and neuroblastomaJ L Daniels, A F Olshan, K Teschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group studyJ M Maris, M J Weiss, C Guo, et al.
The New England Journal of Medicine|November 25, 2005
Chromosome 1p and 11q deletions and outcome in neuroblastomaEdward F Attiyeh, Wendy B London, Yael P Mossé, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 11, 2014
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology GroupRisa Teshiba, Shinya Kawano, Larry L Wang, et al.
Pageof 27